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Abstract
A photocurable thiol-ene network polymer, poly(limonene thioether) (PLT32o), was synthesized, 
characterized, fabricated into tissue engineering scaffolds, and demonstrated in vitro and in vivo. 
Micromolded PLT32o grids exhibited compliant, elastomeric mechanical behavior similar to grids 
made of poly(glycerol sebacate) (PGS), an established biomaterial. Multilayered PL32o scaffolds 
with regular, geometrically defined pore architectures supported heart cell seeding and culture in a 
manner similar to multilayered PGS scaffolds. Subcutaneous implantation of multilayered PLT32o 
scaffolds with cultured heart cells provided long term 3D structural support and retained the 
exogenous cells, whereas PGS scaffolds lost both their structural integrity and the exogenous cells 
over 31 days in vivo. PLT32o membrane implants retained their dry mass, whereas PGS implants 
lost 70 percent of their dry mass by day 31. Macrophages were initially recruited to PLT32o and 
PGS membrane implants but were no longer present by day 31. Facile synthesis and processing in 
combination with the capability to support heart cells in vitro and in vivo suggest that PLT32o can 
offer advantages for tissue engineering applications where prolonged in vivo maintenance of 3D 
structural integrity and elastomeric mechanical behavior are required.
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1. Introduction
Important specifications for tissue engineering templates were recently summarized to 
include: (i) capability to recapitulate the architecture of the niche of the target cells, (ii) 
elastic properties, particularly stiffness, (iii) surface properties to facilitate cell adhesion and 
function and (iv) minimal immunogenicity.[1] While numerous materials are being used for 
tissue engineering research,[2] in the present study we investigate synthetic polymers which, 
as compared with naturally occurring materials, can be more precisely processed into the 3D 
pore architectures that can guide cellular organization, and also afford a wider range of 
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thermomechanical properties.[3-6] Materials-based therapies have been applied to cardiac 
disease [7], which causes significant morbidity and mortality worldwide.[8] These 
approaches have focused on porous elastomeric structural templates that can enable cell 
adhesion and assembly into functional muscle-like tissue.[3, 9, 10-16]
Wang et al.[17] envisioned poly(glycerol sebacate) (PGS) as a synthetic, biocompatible, 
biodegradable elastomer with mechanical properties suitable for medical applications. Solid 
PGS implants degraded by surface erosion, lost >70 % of their dry mass 5 weeks after 
subcutaneous implantation in rats, and did not induce persistent inflammation or scar 
tissue.[18] However, microfabricated PGS degraded quickly, within 2 to 4 weeks in 
vivo,[14, 15] which can be attributed to high surface area per unit mass of thin porous 
scaffolds[4]. These studies, and others,[19-21] demonstrated that PGS degraded too quickly to 
provide long term 3D structural support that could be useful for the regenerative repair of 
soft tissues that are slow to heal, such as infarcted myocardium.[22] Although more slowly 
biodegradable versions of PGS have been invented,[23-26] a photocurable thiol-ene network 
polymer could offer more facile prepolymer synthesis and processing and thereby enable 
more rapid and higher throughput microfabrication into scaffolds with defined 3D pore 
architectures.
The thiol-ene “click reaction” is a powerful synthetic tool that proceeds in the presence of 
oxygen at ambient temperature and in the presence of UV light and a photoinitiator. Hubbell 
and co-workers first described photopolymerizable degradable thiolacrylate systems,[27] and 
Anseth and co-workers custom synthesized and functionalized thiolacrylates to control 
degradation rate and cell-material interactions.[28, 29] Hearon et al.[30] demonstrated a one-
pot synthesis of a thiol-ene polymers wherein brief heating and/or UV irradiation of a 
mixture of trimethylol-propane tris(3-mercaptopropionate) (TMPTMP) and the naturally 
occurring citrus-derived extract D-limonene afforded a homogenous solution that could be 
transferred to a mold without further polymer network formation occurring until subsequent 
exposure to UV irradiation. Synthetic, processing and environmental health and safety 
advantages of PLT32o make this material an attractive candidate for biomedical engineering 
applications where recapitulation of the niche of the target cells through fabrication of 
complex templates with patterned 3D pore microstructures is desired.
The goal of the present study was to investigate whether PLT32o could enable the 
photopolymerization and microfabrication of elastomeric polymer scaffolds with organized 
3D pore microstructures, and provide long in vivo half-life. We reasoned that scaffolds based 
on PLT32o might be of relevance to tissue engineering, and consequently we characterized 
PLT32o with respect to physicochemical properties (wettability, swelling, mechanical 
behavior after microfabrication) and performance as a biomaterial (capability to provide 
heart cells with 3D structural support for 7 days in vitro and 31 days in vivo). PGS, an 
established tissue engineering biomaterial, was selected to serve as a control.
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2. Results
2.1 Polymer chemical structures and analyses
The chemical structures of PLT32o and PGS are respectively shown in Figure 1A and 
Figure 1B. PLT32o is the network polymerization product of a trifunctional alkene 
macromonomer, TMPTMP, end-capped with D-limonene, and a difunctional thiol 
comonomer, 1,10-decanedithiol (1,10 DDT). PGS is the branched polyester polymerization 
product of glycerol and sebacic acid. A photoreactor for carrying out a solvent-free 100 g 
scale synthesis of the PLT32o macromonomer was developed, and after addition of 1,10 
DDT to this macromonomer, PLT32o was photocured by exposure to 365 nm UV light 
under ambient conditions for 2 h. By contrast, PGS preparation was more complex, 
requiring a nitrogen atmosphere for pre-polymer synthesis, heat (≥120°C), vacuum (<40 
mTorr) and an extended time (72 h) for curing. Proton NMR data were recorded for D-
limonene, TMPTMP, and three batches of the unpurified macromonomer shown in Figure 
1A. The three batches of macromonomer exhibited similar chemical shifts and signals, 
suggesting reproducibility of the described synthetic method. Fourier transform infrared 
(FTIR) spectra were also recorded for the aforementioned species. The FTIR spectra 
showed: a C=C stretch at ~1640 cm−1 for D-limonene, C=O functionality at ~1725 cm−1, 
thiol functionality at ~2560 cm−1 for TMPTMP, and both the C=C stretch and the C=O 
stretch for the macromonomer (Figure S1). Additionally, the macromonmer lacked the thiol 
stretch that was present in the TMPTMP starting material. Gel fractions approached 100% 
for both PLT32o and PGS, demonstrating high degrees of network formation and minimal 
sol content after ethanol/water (EtOH/H2O) leaching process used prior to cell culture and 
additional swelling in dichloromethane (DCM) (Figure 1C). Uptakes of phosphate buffered 
saline (PBS) were very low (≤3%) for both PLT32o and PGS, with PLT32o swelling more 
slowly than PGS (Figure 1D). Substrate preconditioning by incubation at 37°C for 48 h in 
serum-supplemented medium markedly improved wettability of PLT32o and PGS, as shown 
by significant reductions in water contact angles (Figure 1E).
2.2 Polymer micromolding
Polymer micromolding by hot embossing[31] was selected as a rapid, high throughput, low 
cost method to create thin layers with rectangular grid-like through-pores and 1:1 aspect 
ratio (height:width) microfeatures. The rectangular through-pore with intervening solid strut 
design was selected because rectangles are structurally anisotropic and are capable of 
aligning collagen fibers,[32] as well as C2C12 myoblasts and heart cells.[10, 12, 13] The 
resolution of this method, determined by the smallest dimension (strut width) of PLT32o and 
PGS grids that could be readily demolded, was ~125 μm. There was no significant difference 
between PLT32o grids and PGS grids with respect to strut width, pore dimensions, or 
thickness (Table 1), and the final grid feature dimensions very closely matched those of the 
master mold.
2.3 Mechanical characterization
To determine mechanical behavior of PLT32o and PGS grids, dynamic mechanical analysis 
and tensile testing until material failure were performed; bulk membranes were also tested to 
provide controls. Dry PLT32o and PGS grids behaved mechanically as compliant 
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elastomers, with high strain-to-failure values exceeding 0.5 mm/mm and low moduli. 
Young's moduli of PLT32o and PGS grids, which did not differ significantly from one 
another, were respectively 410 ± 75.5 kPa and 379 ± 72.6 kPa. Effects of geometry (grid 
versus solid membrane) and material (PLT32o versus PGS) are shown in Figure 2. 
Geometry had a significant effect on all four parameters tested, with lower values obtained 
for grids than for membranes. For the subset of solid membranes, material had a significant 
effect on all four mechanical properties measured, with higher values for PLT32o than PGS.
2.4 Heart cell cultivation on polymer scaffolds
Heart cells were tested on multilayered scaffolds that were fabricated by combining two 
grids made of either PLT32o or PGS with an underlying porous PGS membrane (Figure 3 
A,B). Briefly, the grids were manually aligned and stacked with short strut offset (SSoff), 
solvent bonded together and then the pair was bonded onto a PGS membrane with ~30 μm 
diameter sphere templated pores, as previously described.[15] Heart ventricles were 
harvested from 1 to 2 day old neonatal rats following a protocol according to an Institutional 
Animal Care and Use Committee (IACUC), and heart cells were isolated using a 
GentleMACS Dissociator.[13] Heart cells adhered to and formed multilayered tissue-like 
structures on multilayered scaffolds, as shown by DNA assay of cell number and actin-
phalloidin staining of cell morphology (Figure 3 C-E). Cell number, determined after 2 days 
of culture, showed that heart cells adhered in similar quantities to PLT32o and PGS grids at 
a time point just before the planned implantation in vivo. Cell morphology, determined after 
7 days in vitro, showed similar degrees of heart cell spreading and multicellular tissue 
formation on PLT32o and PGS grids. Heart cells also attached to and remained viable on 
solid PLT32o and PGS membranes with no differences observed between the two materials 
(Figure S1 A,B,G). A murine cell line (C2C12 myoblasts) also showed similar attachment 
to PLT32o and PGS membranes and remained viable on both materials (Figure S1 C-F,H). 
Earlier time points of 1 and 4 days were examined for C2C12 cells which, unlike the heart 
cells, had reached confluence by culture day 4.
2.5 Polymer scaffold degradation and heart cell retention in vivo
To investigate whether multilayered PLT32o or PGS scaffolds with 3D anisotropic pore 
architectures could provide structural support and retain exogenous heart cells upon 
implantation in vivo, the multilayered scaffolds shown in Figure 3 A-B were seeded with 
neonatal rat heart cells and implanted subcutaneously in NIH homozygous RNU nude rats 
according to an IACUC-approved protocol; scaffolds without added heart cells were 
implanted as controls. Explants were harvested after 7 or 31 days and histologically 
evaluated for general appearance by hematoxylin & eosin (H&E) staining and for 
cardiomyocytes by immunostaining for the specific cardiac isoform troponin T (cTnT+). 
PLT32o scaffolds maintained their original 3D pore architectures over the entire 31 day 
study (Figure 4 A-F), whereas PGS scaffolds lost their structural integrity by day 31 (Figure 
4 G-I). Cardiomyocytes were detected at both the 7 and 31 day time points in the group of 
PLT32o scaffolds implanted with exogenous heart cells (Figure 4 E-F). No cardiomyocytes 
were detected at either time point in any of the other three groups, i.e., PLT32o scaffolds 
implanted without exogenous heart cells (Figure 4 B-C), PGS scaffolds implanted with 
exogenous heart cells (Figure 4 H-I) or PGS scaffolds implanted without exogenous cells 
Fischer et al. Page 4
Adv Healthc Mater. Author manuscript; available in PMC 2017 April 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(not shown). Also, the PGS scaffolds completely lost their structural integrity by day 31 
(Figure 4G).
2.6 Time histories of polymer appearance and mass in vivo
Solid polymer membranes were selected for in vivo degradation studies in order to 
accurately assess remaining dry mass, which would not have been feasible after implantation 
of scaffolds due to an inability to separate the polymer from the ingrown tissue. To assess 
polymer degradation kinetics in vivo, solid PLT32o and PGS membranes were implanted 
subcutaneously in Sprague Dawley rats according to an IACUC-approved protocol. Explants 
were evaluated histologically and by dry mass loss after 7, 14, and 31 days in vivo. The 
PLT32o membranes retained their initial dry mass for the entire 31 day study, whereas the 
PGS membranes degraded rapidly after day 14 with a loss of ~70 % of the initial dry mass 
by day 31 (Figure 5A). As a preliminary investigation of host immunological response to 
PLT32o, explanted polymers were stained for the macrophage marker CD68. Macrophages 
that were initially observed to surround the PLT32o and PGS membranes on days 7 and 14 
(Figure 5 B,C,E,F) were essentially no longer present on day 31 (Figure 5 D,G), suggesting 
transient inflammatory responses to both materials as previously described for PGS.[33]
3. Discussion
The present work introduces, characterizes and demonstrates PLT32o, an elastomeric thiol-
ene network polymer, for a soft tissue engineering application. The photoreactor for carrying 
out one-pot, 100 g scale syntheses of PLT32o was a robust system that required no harsh 
chemicals. PLT32o grids were rapidly microfabricated by photocuring in low cost hot-
embossed molds and assembled into multilayered scaffolds with 3D pore architectures. With 
respect to mechanical behavior and compatibility with cultured heart cells, microfabricated 
PLT32o grids performed on par with PGS, a polymer that has been widely used as a tissue 
engineering scaffold for more than a decade.[4, 17-20] PLT32o can potentially advance to the 
field of tissue engineering because, like PGS, PLT32o has physicochemical properties that 
are compatible with cells and tissues but, unlike PGS, PLT32o offers synthetic and 
processing advantages that enable implanted scaffolds with 3D pore architectures to 
maintain their structural integrity and retain exogenous heart cells for 31 days in vivo.
Chemical structures and properties, including a balance of surface hydrophobicity and 
hydrophilicity, wettability and functional groups, contribute importantly to the 
biocompatibility of polymeric materials.[34] PLT32o contains ester and thio-ether linkages in 
its backbone and PGS also contains ester linkages, although PLT32o has substantially fewer 
ester linkages per network repeat unit as compared with PGS. Gel fractions approached 
100% for both PLT32o and PGS, demonstrating high degrees of network formation and <2% 
sol content after the EtOH/H2O leaching process used prior to cell culture. The finding that 
EtOH removed less sol from PLT32o than from PGS and subsequent swelling in DCM 
removed more sol from PLT32o than from PGS could indicate more hydrophilic sol content 
for the PGS (i.e., residual glycerol or sebacic acid monomers and oligomers with pendant 
hydroxyl or carboxylic acid groups) and more hydrophobic sol content for the PLT32o (i.e., 
residual limonene or limonene-capped polythiol species). The wettability of PLT32o and 
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PGS was markedly enhanced by preconditioning substrates in serum-supplemented culture 
medium for 48 h at 37°C, as determined by reduction in water contact angle. This finding, 
which can be attributed to nonspecific adsorption of serum biomolecules, has been 
previously used to precondition polymers by using either serum,[12, 13, 35] or extracellular 
matrix proteins,[36] and has been selected for previous cardiac tissue engineering studies 
based on the reasoning that heart cells should interact with scaffolds only to the degree 
required for retention during surgical handling and localization at the implant site, but not to 
a degree that would inhibit cell-to-cell interaction and multicellular tissue formation either in 
vitro or in vivo. Neither PLT32o nor PGS provides specific functional groups for cell-
receptor binding, and consequently cell adhesion to both polymers is expected to occur 
nonspecifically. An alternative approach others have taken to control cell-polymer 
interactions has been to functionalize polymers, such as by adding RGD to thiol-
acrylates,[29] or YIGSR to PGS.[37]
PLT32o, which is curable by UV irradiation under ambient conditions over 2 h, can be 
rapidly microfabricated at high throughput into scaffolds with defined 3D pore architectures 
as compared with PGS, which requires curing under extreme conditions of heat and vacuum 
for an extended time periods of up to 72 h.[4, 17, 19] By using master molds that were laser 
cut in a few minutes and hot embossed plastic molds that were likewise fabricated in a 
matter of minutes, PLT32o and PGS grids were fabricated with dimensions (125 μm strut 
width, 125 μm layer thickness) suitable for stacking and bonding into multilayered tissue 
engineering scaffolds. The finding of low swelling (≤3%) is expected to facilitate 
micromolding of PLT32o and PGS as compared with hydrogels, such as methacrylated 
gelatin[38] and thiolacrylates.[28] Although silicon wafer molding can be used to fabricate 
PGS grids with smaller strut width (~30 μm) and higher aspect ratio features (~3:1),[12, 13] 
hot embossed molding offers other advantages of rapid prototyping and reduced scaffold 
manufacturing time and cost.[31] Microfabricated PLT32o and PGS grids exhibited 
elastomeric mechanical behaviors and Young's moduli of ~400 kPa; for comparison, Young's 
moduli for human myocardium are reportedly ~10 to 20 kPa at the start of diastole and 200 
to 500 kPa at the end of diastole.[2, 4] One drawback common to both PLT32o and PGS grids 
is that their stiffnesses were too high to permit macroscopic heart cell-mediated contractility. 
Future studies can explore alternative pore designs, such as accordion-like honeycombs, and 
lower polymer volume fractions than the rectangular grids tested herein in an effort to reduce 
scaffold stiffness.[10, 11, 16] Future studies can also investigate the mechanical properties of 
the grids under physiological conditions, as hydration was shown to lower the stiffness of 
electrospun acrylated PGS in vitro,[25] and can address the time history of scaffold 
mechanical properties following implantation.
Multilayered scaffolds based on PLT32o or PGS grids supported the in vitro cultivation of 
heart cells, which attached in similar numbers to both materials and remained attached for at 
least 7 days. Future in vitro studies will be needed to address cytotoxicity over a longer time 
period than 7 days since the findings of the in vivo degradation study suggest that PLT32o 
degradation products would only be produced over an extended time period. As part of an 
ongoing effort to develop thick, viable myocardial grafts by creating a rapidly degradable 
interface to a perfusable microchannel network, two offset grids were bonded to a porous 
PGS membrane in the present study and our previous study,[15] and macroscopic 
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contractions were not observed in either study. Future studies can use more sensitive 
methods to assess contractility, such as force transducers[39] or optical mapping of 
intracellular calcium transients.[40]
Unlike PGS, PLT32o offered synthetic and processing advantages that enable implanted 
scaffolds with 3D pore architectures to maintain their structural integrity and retain 
exogenous heart cells for 31 days in vivo, which can be concluded from the combination of 
the pre-implantation data showing similar initial heart cell numbers and morphologies for 
scaffolds based on either PLT32o grids or PGS grids, and the endpoint histological analyses 
showing retention of structural integrity and cardiomyocytes only for the PLT32o-based 
scaffolds. The finding that PGS scaffolds degraded rapidly could be mitigated to some 
degree by increasing the volume fraction of polymer in the scaffold, but this change would 
also decrease the volume fraction of pores in the scaffold thereby reducing the volume 
available as a niche for heart cell seeding and multicellular tissue assembly. PGS modified 
by acrylation degraded more slowly than PGS [23, 25] but, like other acrylated polymer 
systems,[27, 28] required highly toxic reagents (e.g., acryloyl chloride) for synthesis. PGS 
modified either by introducing amide linkages [24] or by adding silica to form 
nanocomposites [26] also degraded more slowly than PGS, but, like PGS, required extended 
times (24-72 h) and extreme conditions of heat (>120°C) and vacuum (<40 mTorr) for 
polymerization. As such, PLT32o provides synthetic, processing, and/or environmental 
health and safety advantages as compared with slowly degradable versions of PGS that were 
reported previously.
Implanted PLT32o membranes retained their dry mass whereas PGS membranes lost ~70% 
of their initial mass over 31 days in vivo which was similar to previous reports.[4, 18, 19, 21] 
The finding that PLT32o did not biodegrade within 31 days can be explained by its low PBS 
uptake and low average ester composition per network repeat unit as compared with PGS. 
One drawback of PLT32o for tissue engineering applications is that its degradation rate may 
be too slow, as no degradation was measured in the present 31 day in vivo study. Future 
work can include longer in vivo studies, and can explore new PLT formulations with 
degradation rates in-between PGS and PLT32o. The finding that multilayered scaffolds 
based on PLT32o grids retained exogenous cardiomyocytes for 31 days warrants further 
investigation. It is reasonable to expect that heart cell retention can be improved by seeding 
the cells in association with a hydrogel such as fibrin or Matrigel.[16, 41, 42] While PLT32o 
scaffold testing in a cardiac implantation model was beyond the scope of the present work, 
future testing on the myocardium and in the setting of an infarction will be necessary 
because differences in implantation site and local conditions are known to affect the 
degradation rate and performance of biomaterial implants.[43] In a cardiac implant model it 
will be important to determine whether PLT32o scaffolds can support MI healing over its 
typical time course of 4 to 12 weeks,[22] and to quantify vascularization of the scaffold, 
cardiomyocyte survival and retention, and host immune responses.
4. Conclusion
PLT32o, a photocurable elastomeric thiol-ene network polymer, was synthesized, 
characterized, microfabricated and demonstrated in vitro and in vivo in the context of a 
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cardiac tissue engineering scaffold. Micromolded PLT32o grids exhibited compliant 
elastomeric mechanical behavior, and multilayered PLT32o-based scaffolds with 3D pore 
architectures supported heart cell seeding and culture. Subcutaneous implants of 
multilayered PLT32o scaffolds with cultured heart cells provided long term 3D structural 
support for retention of exogenous cells, whereas PGS scaffolds lost both their structural 
integrity and the exogenous cells over 31 days in vivo. PLT32o membrane implants retained 
their dry mass, whereas PGS implants lost 70 percent of their dry mass by day 31. Facile 
synthesis, processing and capabilities to support heart cells in vitro and in vivo suggest that 
PLT32o can offer advantages in tissue engineering or other biomedical engineering 
applications where prolonged in vivo maintenance of 3D structural integrity and elastomeric 
mechanical behavior are required.
5. Experimental Section
Polymer synthesis, micromolding and mechanical characterization
To synthesize PLT32o pre-polymer, a one-pot synthesis,[30] was carried out using a D-
limonene-capped TMPTMP macromonomer similar to the M1 Macromonomer reported in 
Scheme 4 by Claudino et al.[5] and the co-monomer 1,10 DDT. To create a photoreactor, a 
UVP CL-1000 cross-linking chamber with 365 nm bulbs was positioned on top of a 
magnetic stir plate in which UV irradiation of monomers could be carried out under 
vigorous stirring conditions. Step 1 reagents (1.0 molar equivalents limonene (f=2 C=C), 
0.25 molar equivalents of TMPTMP (f = 3 -SH) and 0.25 % (w w−1) 2,2-dimethoxy-2-
phenylacetephenone (DMPA) with respect to Step 1 constituents) were massed in 100 mL 
glass bottles and magnetic stirrers were added to each bottle. For Step 1, each prepolymer 
mixture in 100 mL glass bottles was subjected to ~365 nm UV irradiation for 3 h with 
stirring. After a 3 h photoreaction, Step 2 reagents (0.25 molar equivalents TMPTMP and 
0.25 % (w w−1) DMPA with respect to added Step 2 constituents) were then added to the 
reaction mixtures in the same 100 mL glass bottles and subjected to an additional 3 h of 
irradiation with stirring. For Step 3, 0.575 molar equivalents of 1,10 DDT were added to the 
reaction mixture to afford a prepolymer mixture with a 0.93:1.00 ratio of C=C to SH groups. 
Additional DMPA was also added to the reaction mixtures after Step 3 to afford an overall 
1 % (w w−1) DMPA concentration. PLT32o prepolymer mixtures were heated to 80°C for 20 
min after Steps 1 and 2, and for 1 h after Step 3 to enable DMPA dissolution. PLT32o 
prepolymer mixtures were stored in the dark until needed. To synthesize PGS pre-polymer, a 
previously described method was used with minor modifications.[17] 1.0 mol glycerol and 
1.333 mol sebacic acid were stirred vigorously in a 500 mL round bottom flask under a 
nitrogen atmosphere with a constant nitrogen purge at 140°C for 24 h. After 24 h, PGS 
prepolymer, which was a molten liquid, was poured from the flask in which it was 
synthesized into a 250 mL glass bottle, and 200 proof ethanol was added to the PGS 
prepolymer to afford a working solution of 33 % (w w−1) PGS prepolymer.
Proton NMR data were recorded with a Varian inverse probe INOVA-500 spectrometer with 
a Magnex Scientific superconducting actively shielded magnet, reported in parts per million 
on the δ scale, and referenced from the residual protium in the solvent (CDCl3: δ 7.24),[44] 
displaying a window range of 9 to −0.5 ppm. Infrared data were obtained for the same three 
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materials with a Bruker Alpha FTIR spectrometer. Samples were collected neat on a ZnSe 
ATR crystal, and spectra were reported as percent absorbance as a function of frequency of 
absorption (cm−1). Sol/gel analysis included determining initial dry mass (M0) of cured 
PLT32o or PGS membranes, leaching with shaking at room temperature (RT) for 24 h in 200 
Proof EtOH (>10 mL solvent per 50 mg polymer) leaching with shaking at RT for another 
24 h in dIH2O, for the EtOH/H2O group drying for 18 h at 60°C and 40 mTorr and obtaining 
final mass (Mf), and, for the DCM group, immersion with shaking at RT for another 24 h in 
DCM and then drying and obtaining Mf as described for the EtOH/H2O group. Gel fraction 
was expressed as the ratio of final mass to initial mass (Mf /M0). Swelling was quantified 
measuring intial mass of PLT32o and PGS membranes that were dried for 24 h at 60°C and 
40 mTorr, incubated at RT in PBS at 37°C while shaking, and measuring final mass of 
specimens at timed intervals. PBS uptake was expressed as a percentage (100*Mf /M0). 
Contact angles were measured for PLT32o and PGS membranes after drying for 24 h at 
60°C and 40 mTorr and then again after preconditioning by incubation at 37°C for 48 h in 
serum-supplemented heart cell culture medium. A sessile drop (5 μL) of Ultra-pure water 
was placed on the substrate and the drop profile was recorded at 1 s intervals for 60 s using a 
DSA 100 contact angle system (KRÜSS GmbH, Germany).
PLT32o and PGS grids were fabricated in hot embossed molds. Master molds was made 
from 125 ± 10.2 μm thick poly(imide) (PI) sheets (product #2271K6, McMaster-Carr, 
Robbinsville, NJ) and molds were made either from poly(methyl methacrylate) (PMMA, 5 
cm × 5 cm × 0.599 cm, Interstate Plastics high molecular weight ACRCLCP) or 
polycarbonate (PC, 5 cm × 5 cm × 0.159 cm, McMaster-Carr, Robbinsville, NJ). Master 
molds were fabricated using a programmable Protolaser U3 (LPKF Laser & Electronics, 
Tualatin, OR). Molds were initially embossed at 198°C and 15 psi and 5 min using a 
custom-built laminator and subsequently embossed batch-wise using a Carver Press 
(AutoFour/3012H, Wabash, IN) at 170°C, 16,000 lb and 5 min for PMMA or at 170°C, 
8,000 lb and 20 min for PC.
PLT32o grids were micromolded made by adding prepolymer (20 μL) to a PC mold, 
photocuring at 365 nm for 2 h, and post-curing at 120°C and 15-40 mTorr for 20 h, whereas 
PGS grids were micromolded by pipetting 33 % (w w−1) PGS prepolymer in EtOH (80 μL) 
into a PMMA mold, heating on a 55°C hot plate for 2 h, adding additional PGS prepolymer 
solution (80 μL) into the same mold, and vacuum curing at 120°C and 15-40 mTorr for 72 h. 
Grids were demolded from PMMA by immersion in acetone for ~15 to 40 min or demolded 
from PC by immersion in dioxane for ~10 min. Solid PLT32o membranes were made by 
injecting prepolymer into a chamber between two glass slides (5.08 × 7.62 × 0.1 cm) 
separated by glass spacers (5.08 × 1.0 × 0.1 cm) after coating the glass with Rain-X® 
original to facilitate demolding, and photocuring as described above for PLT32o grids, 
whereas PGS membranes were prepared by casting 33 % (w w−1) PGS prepolymer in EtOH 
on a PMMA surface and evaporating the ethanol on a 55°C hot plate for 4 h, and vacuum 
curing as described above for PGS grids. Grids and membranes were first immersed in 200 
proof EtOH for ~24 h with shaking to remove sol, and then rinsed in dIH2O for ~24 h with 
shaking, and dried at RT. Specimen thicknesses were measured with a dial gauge (accuracy 
0.01 mm; L.S. Starrett Co., Athol, MA). Master molds were imaged with a 200M Axiovert 
microscope (Carl Zeiss, Thornwood, NY) and grids were imaged by SEM (JSM-5600OV, 
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JEOL, Peabody, MA). ImageJ software was used to quantify feature sizes for at least 2 
specimens and 3 fields with 5 to 10 measurements per field.
Mechanical assessments of PLT32o and PGS grids included storage modulus at 1 Hz, 
Young's modulus, ultimate tensile strength (UTS), toughness and strain-to-failure. Grids 
were cut into test strips and tested using a DMA Q800 (TA Instruments, New Castle, DE) 
with an 18 N load cell, in the Multi-Frequency/Strain mode using a preload force of 0.01 N, 
a strain of 0.1 % and a Force Track of 150. On average, the specimens (n ≥7 per group) had 
dimensions of 8.7 mm long x 6.3 mm wide x 0.087 mm thick (for PLT32o) and 8.2 × 6.2 × 
0.091 mm (for PGS). Storage moduli of PLT32o and PGS membranes were assessed as 
described above for grids. Young's moduli, UTS, toughness and strain-to-failure were 
assessed for polymer membrane specimens cut with an ASTM D638 Type V dog bone die 
on model 5943 Instron with a 10 N load cell at a strain rate of 1% s−1. Young's moduli were 
determined by linear regression of the stress strain curve over a strain range of 0.005 to 0.10 
mm mm−1 (R2>0.98); UTS, toughness and strain-to-failure were respectively taken as the 
maximum stress and strain measured prior to the onset of failure and the area under the 
stress-strain curve.[10]
Heart cell studies in vitro and in vivo
In vitro studies and in vivo studies of heart cells were carried out on multilayered scaffolds 
based on PLT32o and PGS grids; solid membrane of PLT32o and PGS provided controls. 
Two geometries were compared for the multi-layered scaffolds: two short strut offset (SSoff) 
PLT32o on a PGS porous membrane versus two SSoff PGS grids on a PGS porous 
membrane. Multilayered scaffolds were made as previously described,[15] by aligning, 
stacking and solvent bonding the 1L grids on a PGS porous membrane, itself made from a 
sintered templates of ~30 μm diameter PMMA microspheres, and curing a weight at 120°C 
and 40 mTorr for 20 h.[15] Substrates were autoclave-sterilized and incubated at 37°C for 48 
h in heart cell culture medium (Dulbecco's Modified Eagle Media supplemented with 2 % 
fetal bovine serum, 10 % horse serum and 1 % penicillin/streptomyocin)[42] prior to cell 
culture. Immediately prior to cell seeding, the substrates were blotted dry and placed within 
polydimethylsiloxane gaskets in 24-well plates.[12] Freshly isolated heart cells were seeded 
at an initial density of ~10 million cells cm−2 (for multilayered scaffolds) or ~0.3 million 
cells cm−2 (for membranes). The number of cells per specimen was assessed by the Quant-
iT Picogreen assay, assuming 8 pg of DNA per cell as previously described.[15] Heart cell 
appearance and viability of cells were assessed by actin-phalloidin staining and Live/Dead 
staining. C2C12 cells (ATCC, Manassas, VA) were also tested on PLT32o and PGS 
membranes and tissue culture polystyrene (TCPS) well-plates using the same methods of 
substrate preparation, tissue culture and analyses that were described for heart cells. The 
C2C12 cells became confluent over 4 days in association with a significant increase in cell 
number between day 1 and 4 as determined by DNA assay.
In vivo studies of multilayered scaffolds with cultured heart cells were carried out in nude 
rats; acellular scaffold implants provided controls. Scaffolds were leached in EtOH/H2O, 
dried, die punched into 6 mm diameter disks, autoclave-sterilized, preconditioned in 
medium, seeded with neonatal rat heart cells at an initial density of ~10 million cells cm−2, 
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cultured for 3 to 4 days in vitro, and implanted into surgically created dorsal subcutaneous 
pouches in nude rats (n=9 male NIH homozygous RNU, 7 to 9 weeks old weighing between 
170 and 323 g). Each rat received implanted samples from multiple experimental groups. 
Specimens were oriented with the grids facing the skin and were loosely fixed to the 
underlying muscle using 6-0 Prolene suture (product# 8697G, Ethicon™). Specimens for 
histological analyses (n=3 with heart cells or n=2 without heart cells per group per time 
point) were harvested en-bloc, fixed in neutral buffered formalin (NBF) for 24 h and stored 
in 70 % EtOH after 7 or 31 days.
In vivo studies of macrophage recruitment and polymer degradation were carried out in 
immunocompetent rats. PLT32o and PGS membranes were leached in EtOH/H2O, dried, 
die-punched into disks (8 mm diameter and 0.5 to 1.0 mm thick), and initial dry mass of 
each disk was recorded for the degradation analysis. Implants were autoclave-sterilized and 
inserted into surgically created dorsal subcutaneous pouches in Sprague-Dawley rats (n=18 
males weighing between 250 and 290 g), with each rat receiving specimens from both 
groups. After 7, 14, or 31 days, specimens designated for degradation analysis (n=4 per 
group per time point) were explanted, denuded of surrounding host tissue, dried at 80°C for 
24 h, and weighed to determine final dry mass. Specimens for histological analyses (n=2 or 
3 per group per time point) were harvested en-bloc, fixed in NBF and stored in 70 % EtOH.
Explanted specimens were embedded in paraffin, sectioned to 5 μm, and stained with H&E 
or immunostained. The primary antibodies and dilution factors were: anti-cardiac troponin T 
(cTnT) (1:400) (MA5-12960, Thermo Fisher, Rockford, IL) and anti-CD68 (1:100) 
(MAB1435, EMD Millipore, Temecula, CA). Briefly, sections were exposed to antigen 
retrieval in citrate buffer antigen at 90°C for 20 min, hydrogen peroxide for 5 min, rodent 
block for 30 min (RBM961, Biocare Medical, Concord, CA), primary antibody for 60 min, 
rat probe for 15 min, rat polymer (RT517, Biocare Medical) for 15 min, and 3,3’-
Diaminobenzidine 10 min prior to coverslipping[45].
Statistical analyses
Statistical significance was assessed by ANOVA with Tukey's post hoc analysis using Prism 
version (v6.0c, Graphpad Software Inc.) Data were reported as average +/− standard 
deviation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Chemical structures and properties of PLT32o and PGS
(A) PLT32o, the network polymerization product of a trifunctional alkene macromonomer 
based on TMPTMP end-capped with D-limonene and the difunctional thiol co-monomer 
1,10 DDT, (B) PGS, the branched polyester polymerization product of glycerol and sebacic 
acid, (C) Gel fractions after leaching in EtOH/H2O and after additional swelling in DCM, 
(D) PBS uptake after incubation at 37°C for 24 or 48 h. (E) Water contact angle initially and 
after preconditioning at 37°C for 48 h in serum-supplemented culture medium. Data show 
AV ± SD for 5 to 8 samples per group; *Significant effects of solvent (C, p<0.0001) and 
preconditioning (E, p<0.0001); **Significant effect of material (C, p<0.005; D, p<0.0001); 
***Significant effect of time (D, p<0.0001).
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Figure 2. Mechanical behaviors of PLT32o and PGS grids and membranes
(A) Storage modulus at 1 Hz, (B) Young's modulus, (C) ultimate tensile strength, (D) 
toughness. Data show AV ± SD for replicates of (A) 7 to 9 or (B-D) 7 to 18. *Significant 
effect of geometry (grid vs. membrane, p<0.0001); **Significant effect of material (PLT32o 
vs. PGS, p<0.0001).
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Figure 3. Multilayered scaffolds for heart cell culture
Scaffolds comprised of (A,C,D) two SSoff PLT32o grids or (B,C,E) two SSoff PGS grids and 
(A-E) an underlying PGS porous membrane. (A,B) SEM images, (C) DNA analyses after 
heart cell culture for 2 days, (D,E) confocal micrographs after heart cell culture for 7 days 
and actin-phalloidin staining. Data show AV ± SD of n=4. Scale bars: 500 μm.
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Figure 4. Multilayered scaffolds based on PLT32o grids maintain their 3D structure and retain 
exogenous heart cells in vivo
(A-C) Scaffolds based on SSoff grids of PLT32o implanted without exogenous heart cells; 
(D-I) Scaffolds based on SSoff grids of (D-F) PLT32o or (G-I) PGS implanted (D-I) with 
exogenous heart cells. Explants were harvested after (A,C,D,F,G,I) 31 days or (B,E,H) 7 
days. Stains: (A,D,G) H&E; (B,C,E,F,H,I) cardiac troponin T (cTnT). Cytoplasmic cTnT 
appears dark brown; nuclei appear blue; polymer appears white. Scale bars: 500 μm (A, D, 
G); 200 μm (B, C, E, F, H, I); 30 μm (B1, C1, E1, F1, H1, I1).
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Figure 5. Time histories of polymer membrane degradation in vivo
(A) Remaining dry mass of PLT32o and PGS membranes (% of initial). *Significantly 
different from the corresponding PLT32o sample (p<0.0002); **Significantly different from 
the corresponding 7 and 14 day PGS samples (p<0.0002). (B-G) Cross sections of (B-D) 
PLT32o and (E-G) PGS explants harvested after (B,E) 7 days, (C,F) 14 days, or (D,G) 31 
days. Stain: CD68 for macrophages (brown, encircled in Insets); nuclei counterstained blue; 
polymer appears white. Scale bars: (B-G) 1 mm; (Insets B1-G1) 100 μm.
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Table 1
Feature sizes of master molds and gridsa
Component Strut width (μm) Short Pore Length (μm) Long Pore Length (μm) Thickness (μm)
PI Master mold 111.8 ± 7.8 393.0 ± 5.7 601.1 ± 15.9
PLT32o Grid 123.3 ± 10.6 361.7 ± 18.5 b 563.6 ± 25.8 b 87.2 ± 10.7
PGS Grid 126.4 ± 39.4 348.8 ± 14.9 b 560.4 ± 19.7 b 91.0 ± 14.6
a
Data show the AV ± SD of 30 measurements for all data except grid thicknesses where data show the AV ± SD of at least 10 measurements.
bStatistically different from corresponding value measured for the PI Master mold.
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